Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy

Thoracic Cancer ◽

10.1111/1759-7714.14256 ◽

2021 ◽

Author(s):

Giuseppe L. Banna ◽

Marcello Tiseo ◽

Diego L. Cortinovis ◽

Francesco Facchinetti ◽

Joachim G. J. V. Aerts ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Inflammatory Markers ◽

Performance Status ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung ◽

First Line

Download Full-text

First-Line Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181cee1ea ◽

2010 ◽

Vol 5 (3) ◽

pp. 361-368 ◽

Cited By ~ 14

Author(s):

Young Joo Lee ◽

Heung Tae Kim ◽

Ji-Youn Han ◽

Tak Yun ◽

Geon Kook Lee ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung ◽

First Line ◽

Gefitinib Treatment

Download Full-text

Faculty Opinions recommendation of Palliative thoracic radiotherapy for patients with advanced non-small cell lung cancer and poor performance status.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725268190.793503674 ◽

2015 ◽

Author(s):

Mellar Davis

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text

Patients with non-small cell lung cancer and poor performance status: A significant population with limited data

Seminars in Oncology ◽

10.1053/j.seminoncol.2004.10.001 ◽

2004 ◽

Vol 31 ◽

pp. 1-2

Author(s):

Corey Langer ◽

Rogerio Lilenbaum

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Limited Data ◽

Small Cell Lung

Download Full-text

Evaluation of efficacy and safety of gefitinib as monotherapy in Chinese patients with advanced non-small cell lung cancer and very poor performance status

BMC Research Notes ◽

10.1186/1756-0500-1-102 ◽

2008 ◽

Vol 1 (1) ◽

pp. 102 ◽

Cited By ~ 6

Author(s):

Zhong Wei ◽

Wang Mengzhao ◽

Zhang Li ◽

Li Longyun ◽

Zhang Xiaotong

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Small Cell ◽

Chinese Patients ◽

Poor Performance Status ◽

Efficacy And Safety ◽

Small Cell Lung

Download Full-text

141: Small cell lung cancer: Is there a role for chemotherapy in patients with poor performance status?

Lung Cancer ◽

10.1016/s0169-5002(17)30191-5 ◽

2017 ◽

Vol 103 ◽

pp. S64

Author(s):

S. Massalha ◽

A. Mullard ◽

C. Fuller

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung

Download Full-text

Retrospective analysis of the management of extensive stage small cell lung cancer (SCLC) in patients with a poor performance status

Lung Cancer ◽

10.1016/s0169-5002(19)30246-6 ◽

2019 ◽

Vol 127 ◽

pp. S84

Author(s):

T. Moore ◽

L. Gossage ◽

C. Lopez Escola ◽

I. Hennig

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Retrospective Analysis ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung ◽

Extensive Stage

Download Full-text

Challenges in defining and identifying patients with non-small cell lung cancer and poor performance status

Seminars in Oncology ◽

10.1053/j.seminoncol.2004.10.003 ◽

2004 ◽

Vol 31 ◽

pp. 3-7 ◽

Cited By ~ 18

Author(s):

Karen Kelly

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung

Download Full-text

P-579 Topotecan in the treatment of relapsed small cell lung cancer patients with poor performance status

Lung Cancer ◽

10.1016/s0169-5002(03)92546-3 ◽

2003 ◽

Vol 41 ◽

pp. S237 ◽

Cited By ~ 2

Author(s):

Joseph Treat ◽

Chao Hui Huang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Poor-Performance Status Assessment of Patients with Non-small Cell Lung Cancer Remains Vague and Blurred in the Immunotherapy Era

Current Oncology Reports ◽

10.1007/s11912-019-0852-9 ◽

2019 ◽

Vol 21 (12) ◽

Cited By ~ 13

Author(s):

Alex Friedlaender ◽

Giuseppe Luigi Banna ◽

Lucio Buffoni ◽

Alfredo Addeo

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung ◽

Status Assessment

Download Full-text

Outcomes of EGFR-TKIs for patients with non-small cell lung cancer harboring EGFR mutations with poor performance status

Annals of Oncology ◽

10.1093/annonc/mdy425.029 ◽

2018 ◽

Vol 29 ◽

pp. ix160

Author(s):

K. Hashimoto ◽

Y. Okuma ◽

T. Hakozaki ◽

K. Watanabe ◽

Y. Hosomi

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Small Cell ◽

Egfr Mutations ◽

Poor Performance Status ◽

Small Cell Lung ◽

Egfr Tkis

Download Full-text